
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based vaccine against pneumococcal disease, developed …

The multi-product facility recently underwent significant renovations

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of …

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …

Interim report January – September 2017 July – September 2017

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …

Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …

Contract development and manufacturing organisation Recipharm has appointed Thomas Beck to the new senior role of vice president of quality …

Contract development and manufacturing organisation Recipharm has hired two new directors for its business management unit. Henning Neubauer (pictured) takes …

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …